John Joseph Borg is an expert in Pharmacy at University of Rome Tor Vergata (Italy). John Joseph Borg has authored 46 publications, the most recent in 2025. SLR score: 140 (community average: 125). How the SLR is computed.

LeadR Profile

John Joseph Borg University of Rome Tor Vergata Italy
140 ScienceLeadR Reputation 140
Network Map

Pharmacy

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2002 - 2025

Source: PubMed

University of Rome Tor Vergata

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 46

Citations

Citations: 646 1st author: 12 Last author: 17 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The value of a structured, systematic approach to benefit-risk assessment of medicines: A South African regulator case study.
PMID 40581143 — risk assessment, pharmacology, toxicology
Regul Toxicol Pharmacol20250
The European Innovation Network as a hub for medicines innovation in Europe.
PMID 38467771 — pharmaceutical preparations
Nat Rev Drug Discov Top journal20240
An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta.
PMID 38820023 — nurses, jurisprudence, pharmaceutical preparations, pharmacists, decision making, risk management, health knowledge, attitudes, practice, drug-related side effects and adverse reactions, physicians, dentists, pharmacovigilance
Int J Risk Saf Med20241
An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance.
PMID 37707778 — drug-related side effects and adverse reactions, pharmaceutical preparations, hemorrhage, toxicology, covid-19 vaccines
Drug Saf20236
Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective.
PMID 37383710 — pharmacology, oligodeoxyribonucleotides, neuroinflammatory diseases
Front Pharmacol20230

LeadR Networks

Main global connection map